Abstract
Background Colleges and universities across the United States are developing and implementing data-driven prevention and containment measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Identifying risk factors for SARS-CoV-2 seropositivity could help to direct these efforts.
Objective To estimate the associations between demographic factors and social behaviors and SARS-CoV-2 seropositivity and self-reported positive SARS-CoV-2 diagnostic test.
Methods In September 2020, we randomly sampled Indiana University Bloomington (IUB) undergraduate students. Participants completed a cross-sectional, online survey about demographics, SARS-CoV-2 testing history, relationship status, and risk behaviors. Additionally, during a subsequent appointment, participants were tested for SARS-CoV-2 antibodies using a fingerstick procedure and SARS-CoV-2 IgM/IgG rapid assay kit. We used unadjusted modified Poisson regression models to evaluate the associations between predictors of both SARS-CoV-2 seropositivity and self-reported positive SARS-CoV-2 infection history.
Results Overall, 1,076 students were included in the serological testing analysis, and 1,239 students were included in the SARS-CoV-2 infection history analysis. Current seroprevalence of SARS-CoV-2 was 4.6% (95% CI: 3.3%, 5.8%). Prevalence of self-reported SARS-CoV-2 infection history was 10.3% (95% CI: 8.6%, 12.0%). Greek membership, having multiple romantic partners, knowing someone in one’s immediate environment with SARS-CoV-2 infection, drinking alcohol more than 1 day per week, and hanging out with more than 4 people when drinking alcohol increased both the likelihood of seropositivity and SARS-CoV-2 infection history.
Conclusion Our findings have implications for American colleges and universities and could be used to inform SARS-C0V-2 prevention and control strategies on such campuses.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The current study design is cross-sectional. However, the parent study is a randomized controlled trial and is registered on ClinicalTrials.gov (ID: NCT04620798).
Clinical Protocols
https://clinicaltrials.gov/ct2/show/NCT04620798
Funding Statement
This study was supported by private contributions to the Indiana University Foundation. The United Arab Emirates provided the testing kits.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Indiana University's Human Subjects & Institutional Review Boards gave ethical approval for this study's protocol (Protocol #2008293852, Review Type: Expedited, Status: Approved).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations
Conflict of interest: None
Funding: This study was supported by private contributions to the Indiana University Foundation. The United Arab Emirates provided the testing kits.
Ethics approval: The Indiana University Office of Research Compliance approved the study protocol (protocol #2008293852).
Data Availability
Data are available upon request.
Data Availability
Available upon request
